Biohaven Ltd. (NYSE:BHVN) traded at $19.20 at close of the session on Monday, 01/23/23, made an upward move of 4.12% on its previous day’s price.
Looking at the stock we see that its previous close was $18.44 with the day’s price range being $18.27 – $20.00. In terms of its 52-week price range, BHVN has a high of $18.78 and a low of $5.54. The company’s stock has gained about 36.07% over that past 30 days.
Biohaven Ltd. has a market cap of $1.31 billion and is expected to release its quarterly earnings report on Feb 23, 2023 – Feb 27, 2023. Estimates by analysts give the company expected earnings per share (EPS) of -$2.34, with the EPS growth for the year raised at -$11.55 for 2022 and -$5.7 for next year.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term.
Based on estimates by 7 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Biohaven Ltd. (BHVN) stock as a Hold, while 7 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 26.00% off its SMA20 and 25.30% from its 50-day simple moving average. The RSI (14) is pointing at 65.79 while the volatility over the past week is 9.58% and jumps to 8.89% over the past one month. The average price target for the stock over the next 12 months is $46.67, with the estimates having a low of $21.00 and a high of $160.00. These price ends are -9.38% and -733.33% off the current price level respectively, although investors could be excited at the prospect of a -27.6% if the BHVN share price touches on the median price of $24.50.
Coming back to Biohaven Ltd. (NYSE:BHVN), we note that the average 3-month trading volume was 1.31 million, while that of the preceding 10-day period stands at 1.21 million. Current shares outstanding are 68.16 million.
The insiders hold 14.67% of the company’s shares while institutions hold 36.83%. The data shows that short shares as of Oct 13, 2022, stood at 2.69 million at a short ratio of 0.78. This represents a 6.82% short interest in shares outstanding on Oct 13, 2022. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 38.33% up in year-to-date price movement.